Age-related Cognitive Decline Clinical Trial
Official title:
Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiome: A Randomized, Double-blind, Placebo-controlled Intervention
The aim of the current study is to investigate whether acute and 12-weeks daily intake of Nordic berries can improve cognitive abilities of adults without cognitive disease, and whether the effect can be linked to changes in metabolic parameters.
The study will be conducted with a randomized, double-blind, parallel-group (2 arms) placebo-controlled, single-center interventional design. The aim is to investigate the effects on cognitive function and cardiometabolic risk markers after acute and 12 weeks daily intake of a berry product vs. a reference product. The reference will be isocaloric and matched in taste, appearance, volume and macronutrient composition to the active berry product. Two groups, each of 30 volunteers, are studied. One group of volunteers will consume the berry product while the other group act as control and will consume the reference product. Each volunteer will be seen for a screening visit as well as one pre- and one post-intervention visit at the clinic. In addition, there will be 2 follow-up calls in between visits. Pre- and post intervention visits will include cognitive assessment with the CANTAB battery (episodic memory and verbal recognition memory), as well as additional cognitive and behavioral tests. Cardiometabolic parameters will be addressed (plasma glucose, insulin, inflammatory markers, blood lipids, body composition) and fecal samples collected. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04121728 -
Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT03228446 -
The Effects of Attentional Filter Training on Working Memory
|
N/A | |
Completed |
NCT04910399 -
Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging
|
N/A | |
Recruiting |
NCT03275363 -
The University of Hong Kong Neurocognitive Disorder Cohort
|
N/A | |
Completed |
NCT02185222 -
Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint
|
Phase 3 | |
Completed |
NCT03162913 -
The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults
|
N/A | |
Completed |
NCT02416401 -
Attention Training for Learning Enhancement and Resilience Trial
|
N/A | |
Completed |
NCT02922920 -
Effects of Tart Cherry Juice on the Body
|
N/A | |
Completed |
NCT01120860 -
Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator Performance
|
N/A | |
Recruiting |
NCT03702335 -
Impact of Comprehensive Dietary Counseling on Dietary Quality, Mental Health, and Quality of Life in Older Adults
|
N/A | |
Completed |
NCT05828043 -
Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline
|
N/A | |
Active, not recruiting |
NCT05348694 -
OsteoPreP: Food Supplements for Postmenopausal Bone Health
|
Phase 4 | |
Recruiting |
NCT05194787 -
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
|
||
Recruiting |
NCT04184375 -
Cognitive Stimulation for Elderly Bipolar Patients
|
N/A | |
Recruiting |
NCT04171323 -
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
|
N/A | |
Not yet recruiting |
NCT06248723 -
ItaliaN Study With Tailored Multidomain Interventions to Prevent Functional and Cognitive Decline in Community-dwelling Older Adults
|
N/A | |
Terminated |
NCT04732312 -
Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment
|
||
Recruiting |
NCT06377254 -
Multi-organ Responses to CHronic Physical Activity and INactivity
|
N/A | |
Not yet recruiting |
NCT04566757 -
Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline
|
Phase 1 |